NCT01646151View on ClinicalTrials.gov

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

CompletedOBSERVATIONAL

Enrollment

2,580

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

Bimatoprost

Bimatoprost-containing eye drops administered in the affected eye(s) at a dose determined by the physician in accordance with standard of care for up to 12 weeks.

Trial Locations (2)

Unknown

Dresden

Amsterdam